In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Neogenomics Inc (NASDAQ: NEO) closed at $8.20 in the last session, down -7.13% from day before closing price of $8.83. In other words, the price has decreased by -$7.13 from its previous closing price. On the day, 2.01 million shares were traded. NEO stock price reached its highest trading level at $9.22 during the session, while it also had its lowest trading level at $8.1601.
Ratios:
We take a closer look at NEO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.89 and its Current Ratio is at 1.98. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.44.
On December 10, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $22.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 15 ’24 when Olivo Alicia C sold 5,175 shares for $15.36 per share. The transaction valued at 79,475 led to the insider holds 37,129 shares of the business.
ALICIA OLIVO bought 5,175 shares of NEO for $81,713 on Nov 15 ’24. On Aug 15 ’24, another insider, Olivo Alicia C, who serves as the General Counsel of the company, sold 1,040 shares for $16.05 each. As a result, the insider received 16,695 and left with 43,813 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NEO now has a Market Capitalization of 1053380160 and an Enterprise Value of 1346380928. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.59 while its Price-to-Book (P/B) ratio in mrq is 1.16. Its current Enterprise Value per Revenue stands at 2.038 whereas that against EBITDA is 1580.259.
Stock Price History:
The Beta on a monthly basis for NEO is 1.47, which has changed by -0.43291837 over the last 52 weeks, in comparison to a change of -0.034466684 over the same period for the S&P500. Over the past 52 weeks, NEO has reached a high of $19.11, while it has fallen to a 52-week low of $8.15. The 50-Day Moving Average of the stock is -26.39%, while the 200-Day Moving Average is calculated to be -43.01%.
Shares Statistics:
According to the various share statistics, NEO traded on average about 1.40M shares per day over the past 3-months and 1800530 shares per day over the past 10 days. A total of 128.15M shares are outstanding, with a floating share count of 126.92M. Insiders hold about 1.20% of the company’s shares, while institutions hold 101.37% stake in the company. Shares short for NEO as of 1741910400 were 4224233 with a Short Ratio of 3.01, compared to 1739491200 on 3434219. Therefore, it implies a Short% of Shares Outstanding of 4224233 and a Short% of Float of 4.5600000000000005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
